KUALA LUMPUR, April 13 (Bernama) -- Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, has announced a strategic partnership with Camtech Diagnostics (Camtech).
According to a statement, Camtech is a technology company providing total solutions to the biodefence, food and clinical diagnostics sectors.
The partnership covers the distribution of Congenica’s platform in Asia-Pacific.
Under the partnership agreement, Camtech will be responsible for the marketing, distribution and sales of Congenica’s clinical decision support platform in Singapore, Malaysia, Japan and South Korea.
Congenica’s platform is proven to enable rapid analysis of genomic data, allowing medical labs to deliver personalised medicine at scale.
Congenica has an existing presence in China and this latest agreement will support continued expansion in the rare disease market in the Asia-Pacific region.
Camtech has significant experience in the healthcare diagnostics industry, having launched novel laboratory-based and point-of-care diagnostic tests to the market.
It also has expertise in Next Generation Sequencing, laboratory based and digital health solutions, which will be complementary to Congenica’s solution.
“Global expansion remains a priority for Congenica and entry into these key territories signifies further strategic progress whilst opening up significant new markets for Congenica’s leading genomic analysis platform,” said Congenica Chief Commercial Officer, Muthu Meyyappan, PhD.
-- BERNAMA
No comments:
Post a Comment